- Recent Funding
- Investors
- Grand Pharma
Grand Pharma portfolio
Grand Pharma has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is eTheRNA Immunotherapies's $39M Series B+ round in August 2022, alongside EQT Life Sciences, Fund+, Omega Funds and 3 others. That company is in Health and bio.
What Grand Pharma invests in
- Health and bio · 1 · 100%
How Grand Pharma invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $39M |
Grand Pharma portfolio companies
EeTheRNA Immunotherapies$39MSeries B+ · Aug 2022
| Company | Round with Grand Pharma | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $39M | $104.41M | Aug 24, 2022 Series B+ |
Most frequent co-investors
PPMV1 shared round · last Aug 24, 2022
EEQT Life Sciences1 shared round · last Aug 24, 2022
OOmega Funds1 shared round · last Aug 24, 2022
FFund+1 shared round · last Aug 24, 2022
NNovalis LifeSciences1 shared round · last Aug 24, 2022
KKenneth Chien1 shared round · last Aug 24, 2022
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Grand Pharma. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Grand Pharma, which is a subset of its real portfolio. API: /api/v1/investors/grand-pharma (get a free API key). More: the most active VC firms and new venture capital funds.